Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Original Articles

5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control

Yousefzadeh, Farzaneha; Sahebolzamani, Erfana; Sadri, Arasha; Mortezaei, Amirhoseina; Aqamolaei, Alia; Mortazavi, Seyyed Hoseina; Shalbafan, Mohammd Rezab; Ghaffari, Salomehc; Alikhani, Rosad; Mousavi, Seiedeh Bentolhodad; Naderi, Sinaa; Shamabadi, Ahmada; Jalilevand, Shakibaa; Akhondzadeh, Shahina

Author Information
International Clinical Psychopharmacology: September 2020 - Volume 35 - Issue 5 - p 254-262
doi: 10.1097/YIC.0000000000000321
  • Buy

Abstract

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.